These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2231594)

  • 1. Phosphorus-containing inhibitors of HMG-CoA reductase. 1. 4-[(2-arylethyl)hydroxyphosphinyl]-3-hydroxy-butanoic acids: a new class of cell-selective inhibitors of cholesterol biosynthesis.
    Karanewsky DS; Badia MC; Ciosek CP; Robl JA; Sofia MJ; Simpkins LM; DeLange B; Harrity TW; Biller SA; Gordon EM
    J Med Chem; 1990 Nov; 33(11):2952-6. PubMed ID: 2231594
    [No Abstract]   [Full Text] [Related]  

  • 2. Phosphorus-containing inhibitors of HMG-CoA reductase. 2. Synthesis and biological activities of a series of substituted pyridines containing a hydroxyphosphinyl moiety.
    Robl JA; Duncan LA; Pluscec J; Karanewsky DS; Gordon EM; Ciosek CP; Rich LC; Dehmel VC; Slusarchyk DA; Harrity TW
    J Med Chem; 1991 Sep; 34(9):2804-15. PubMed ID: 1895299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and biological activity of new HMG-CoA reductase inhibitors. 3. Lactones of 6-phenoxy-3,5-dihydroxyhexanoic acids.
    Jendralla H; Granzer E; von Kerekjarto B; Krause R; Schacht U; Baader E; Bartmann W; Beck G; Bergmann A; Kesseler K
    J Med Chem; 1991 Oct; 34(10):2962-83. PubMed ID: 1656041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitors of acyl-CoA:cholesterol O-acyltransferase (ACAT) as hypocholesterolemic agents: synthesis and structure-activity relationships of novel series of sulfonamides, acylphosphonamides and acylphosphoramidates.
    Lee HT; Roark WH; Picard JA; Sliskovic DR; Roth BD; Stanfield RL; Hamelehle KL; Bousley RF; Krause BR
    Bioorg Med Chem Lett; 1998 Feb; 8(3):289-94. PubMed ID: 9871672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of some 3-hydroxy-5-aminopentanoic acid derivatives.
    Carganico G; Cangiano G; Cozzi P; Lovisolo PP
    Farmaco Sci; 1987 Apr; 42(4):277-84. PubMed ID: 3595839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of humidity-dependent changes in crystal structure on the solid-state fluorescence properties of a new HMG-CoA reductase inhibitor.
    Brittain HG; Ranadive SA; Serajuddin AT
    Pharm Res; 1995 Apr; 12(4):556-9. PubMed ID: 7596991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitors of cholesterol biosynthesis. 4. trans-6-[2-(substituted-quinolinyl)ethenyl/ethyl]tetrahydro-4-hydroxy-2 H-pyran-2-ones, a novel series of HMG-CoA reductase inhibitors.
    Sliskovic DR; Picard JA; Roark WH; Roth BD; Ferguson E; Krause BR; Newton RS; Sekerke C; Shaw MK
    J Med Chem; 1991 Jan; 34(1):367-73. PubMed ID: 1992138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 3-Alkyl-3-hydroxyglutaric acids: a new class of hypocholesterolemic HMG CoA reductase inhibitors. 1.
    Baran JS; Laos I; Langford DD; Miller JE; Jett C; Taite B; Rohrbacher E
    J Med Chem; 1985 May; 28(5):597-601. PubMed ID: 3989819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Species differences in the inhibiting effect of fluvastatin, a new inhibitor of HMG-CoA reductase, on cholesterol biosynthesis.
    Yamamoto A; Itoh S; Hoshi K; Ichihara K
    Res Commun Mol Pathol Pharmacol; 1994 Dec; 86(3):325-34. PubMed ID: 7712108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, biological profile, and quantitative structure-activity relationship of a series of novel 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors.
    Sit SY; Parker RA; Motoc I; Han W; Balasubramanian N; Catt JD; Brown PJ; Harte WE; Thompson MD; Wright JJ
    J Med Chem; 1990 Nov; 33(11):2982-99. PubMed ID: 2231596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitors of cholesterol biosynthesis. 3. Tetrahydro-4-hydroxy-6-[2-(1H-pyrrol-1-yl)ethyl]-2H-pyran-2-one inhibitors of HMG-CoA reductase. 2. Effects of introducing substituents at positions three and four of the pyrrole nucleus.
    Roth BD; Blankley CJ; Chucholowski AW; Ferguson E; Hoefle ML; Ortwine DF; Newton RS; Sekerke CS; Sliskovic DR; Stratton CD
    J Med Chem; 1991 Jan; 34(1):357-66. PubMed ID: 1992137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypocholesterolemic activity of synthetic and natural tocotrienols.
    Pearce BC; Parker RA; Deason ME; Qureshi AA; Wright JJ
    J Med Chem; 1992 Oct; 35(20):3595-606. PubMed ID: 1433170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacodynamics and pharmacokinetics of the HMG-CoA reductase inhibitors. Similarities and differences.
    Lennernäs H; Fager G
    Clin Pharmacokinet; 1997 May; 32(5):403-25. PubMed ID: 9160173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between tissue selectivity and lipophilicity for inhibitors of HMG-CoA reductase.
    Roth BD; Bocan TM; Blankley CJ; Chucholowski AW; Creger PL; Creswell MW; Ferguson E; Newton RS; O'Brien P; Picard JA
    J Med Chem; 1991 Jan; 34(1):463-6. PubMed ID: 1992149
    [No Abstract]   [Full Text] [Related]  

  • 15. (E)-4-(2-[[3-(indol-5-yl)-1-oxo-2-butenyl]amino]phenoxy)butyric acid derivatives: a new class of steroid 5 alpha-reductase inhibitors in the rat prostate. 1.
    Kumazawa T; Takami H; Kishibayashi N; Ishii A; Nagahara Y; Hirayama N; Obase H
    J Med Chem; 1995 Jul; 38(15):2887-92. PubMed ID: 7636849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitors of cholesterol biosynthesis. 6. trans-6-[2-(2-N-heteroaryl-3,5-disubstituted- pyrazol-4-yl)ethyl/ethenyl]tetrahydro-4-hydroxy-2H-pyran-2-ones.
    Sliskovic DR; Blankley CJ; Krause BR; Newton RS; Picard JA; Roark WH; Roth BD; Sekerke C; Shaw MK; Stanfield RL
    J Med Chem; 1992 May; 35(11):2095-103. PubMed ID: 1597859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitors of cholesterol biosynthesis. 2. Hypocholesterolemic and antioxidant activities of benzopyran and tetrahydronaphthalene analogues of the tocotrienols.
    Pearce BC; Parker RA; Deason ME; Dischino DD; Gillespie E; Qureshi AA; Volk K; Wright JJ
    J Med Chem; 1994 Feb; 37(4):526-41. PubMed ID: 8120870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of early cholesterol biosynthesis in rat liver: effects of sterols, bile acids, lovastatin, and BM 15.766 on 3-hydroxy-3-methylglutaryl coenzyme A synthase and acetoacetyl coenzyme A thiolase activities.
    Honda A; Salen G; Nguyen LB; Xu G; Tint GS; Batta AK; Shefer S
    Hepatology; 1998 Jan; 27(1):154-9. PubMed ID: 9425931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A potent, tissue-selective, synthetic inhibitor of HMG-CoA reductase.
    Balasubramanian N; Brown PJ; Catt JD; Han WT; Parker RA; Sit SY; Wright JJ
    J Med Chem; 1989 Sep; 32(9):2038-41. PubMed ID: 2769677
    [No Abstract]   [Full Text] [Related]  

  • 20. Compactin (ML-236B) and related compounds as potential cholesterol-lowering agents that inhibit HMG-CoA reductase.
    Endo A
    J Med Chem; 1985 Apr; 28(4):401-5. PubMed ID: 3981532
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.